Case Report: Microincision Vitreous Surgery Induces Bleb Failure in Eyes With Functional Filtering Bleb

Satomi Oogi; Shunsuke Nakakura; Ryo Asaoka; Etsuko Terao; Saki Dote; Kanae Matsuya; Yui Kimura

doi:10.3389/fmed.2022.847660

Case Report: Microincision Vitreous Surgery Induces Bleb Failure in Eyes With Functional Filtering Bleb

Front Med (Lausanne). 2022 Feb 21:9:847660. doi: 10.3389/fmed.2022.847660. eCollection 2022.

Authors

Satomi Oogi¹, Shunsuke Nakakura¹, Ryo Asaoka^{2

3

4

5

6}, Etsuko Terao¹, Saki Dote¹, Kanae Matsuya¹, Yui Kimura¹

Affiliations

¹ Department of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, Japan.
² Department of Ophthalmology, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
³ Seirei Christopher University, Hamamatsu, Japan.
⁴ Nanovision Research Division, Research Institute of Electronics, Shizuoka University, Hamamatsu, Japan.
⁵ The Graduate School for the Creation of New Photonics Industries, Hamamatsu, Japan.
⁶ Department of Ophthalmology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Tokyo, Japan.

Abstract

Purpose: To investigate the effect of microincision vitreous surgery (MIVS) on intraocular pressure (IOP) control in glaucomatous eyes with functional filtering bleb.

Methods: We enrolled 18 patients (15 males; median age, 73 years) who previously had filtering surgery and underwent MIVS with functional filtering bleb. Kaplan-Meier method was used to calculate the survival rate with defined the failure as when more number of preoperative antiglaucoma medication was started or additional glaucoma surgery including bleb revisions were performed, and IOP increase of 20% (criteria 1) and 30% (criteria 2) from preoperative levels after 2 weeks of MIVS.

Results: The median follow-up duration was 970 days. Preoperative IOP was 13.3 ± 3.8 mmHg (mean ± SD). Postoperative IOP were 14.7 ± 4.9 (P=0.365), 15.2 ± 3.5 (P=0.137), 16.4 ± 5.6 (P = 0.073), 17.6 ± 6.1(P = 0.020), and 14.5 ± 4.0 (P = 0.402) mmHg at 3, 6, 12, and 15 months and final visit, respectively (compared to preoperative IOP). The number of antiglaucoma medications was a median of 1.0 (range 0-4) preoperatively and 0 (0-4) at the final visit (P = 0.238). The survival rates were 55%/61% at 3 months, 50%/61% at 6 months, and 38%/55% at 12 months with criteria 1 and 2, respectively. Four eyes (22%) received additional glaucoma surgery during follow-up.

Conclusion: After several months of MIVS, IOP was likely to increase. We should focus on IOP control by conducting long-term follow-ups.

Keywords: Ex-PRESS; IOP (intraocular pressure); glaucoma; microincision vitreous surgery; trabeculectomy.

Publication types

Case Reports